2026-01-19
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
2026-01-04
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
2025-12-19
Scientists Crack the "Xenogeneic Barrier", Offering a New Path for Growing Human Organs in Animals
For a long time, human cells have often been excluded and struggled to survive in animal embryos due to the "xenogeneic barrier." The mainstream strategy in the past involved genetically engineering human cells to enhance their anti-apoptotic capabilities, but this approach carries potential safety risks such as carcinogenesis. How can this barrier be overcome more safely? A collaborative team led by the University of Texas Southwestern Medical Center and BGI Research used mice as a model to tackle this issue and achieved a critical breakthrough.
2025-12-19
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.
2025-12-12
No Need for Open-Chest Surgery: Stem Cell Patch Enables Minimally Invasive Heart Repair
Recently, a joint research team from the Mayo Clinic and the University of Nebraska Medical Center published a breakthrough study in the Journal of Biomedical Materials Research—they successfully developed a minimally implantable stem cell patch that can repair damaged hearts without open-chest surgery, providing a safer treatment option for heart failure patients. This achievement signifies the deep integration of regenerative medicine and minimally invasive interventional technology, which is expected to reshape the clinical approach to heart repair.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
